Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Channel Therapeutics Corp (CHRO)

Channel Therapeutics Corp (CHRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,978
  • Shares Outstanding, K 6,028
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,380 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.15
  • Most Recent Earnings $-0.29 on 11/13/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4500 +46.67%
on 11/19/24
0.9327 -29.24%
on 10/24/24
-0.0400 (-5.71%)
since 10/22/24
3-Month
0.4500 +46.67%
on 11/19/24
1.1100 -40.54%
on 09/26/24
-0.2063 (-23.81%)
since 08/22/24

Most Recent Stories

More News
Channel Therapeutics Corporation Announces Name Change Reflecting Focus on Non-Opioid Pain Therapeutics

Channel Therapeutics rebrands to focus on sodium channel-based pain treatments, anticipating key efficacy data soon.Quiver AI SummaryChromocell Therapeutics Corporation has officially changed its name...

CHRO : 0.6600 (+4.56%)
Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates

CHRO : 0.6600 (+4.56%)
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

CHRO : 0.6600 (+4.56%)
Chromocell to Present at Upcoming Fall Investor Conferences

CHRO : 0.6600 (+4.56%)
Chromocell Announces Amendment to Stock Repurchase Plan

CHRO : 0.6600 (+4.56%)

Business Summary

Chromocell Therapeutics Corporation is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive, therapeutics to alleviate pain and other associated medical conditions. Chromocell Therapeutics Corporation is based in FREEHOLD, N.J.

See More

Key Turning Points

3rd Resistance Point 0.7487
2nd Resistance Point 0.7056
1st Resistance Point 0.6828
Last Price 0.6600
1st Support Level 0.6169
2nd Support Level 0.5738
3rd Support Level 0.5510

See More

52-Week High 6.0000
Fibonacci 61.8% 3.8799
Fibonacci 50% 3.2250
Fibonacci 38.2% 2.5701
Last Price 0.6600
52-Week Low 0.4500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar